Lexicon Pharmaceuticals (LXRX) Prepaid Assets (2010 - 2026)
Lexicon Pharmaceuticals (LXRX) reported Prepaid Assets of $3.3 million for Q1 2026, little changed year-over-year from $3.3 million in Q1 2025, and up 10.63% quarter-over-quarter from $3.0 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Prepaid Assets (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 17 years of Prepaid Assets data on file, last reported at $3.3 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $3.3 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (changed 0.0% YoY), and the FY2025 annual result was $3.0 million, down 33.8% from the prior year.
- Prepaid Assets advanced to $3.3 million in Q1 2026 per LXRX's latest filing, from $3.0 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $7.7 million in Q2 2024 and troughed at $1.9 million in Q1 2022.
- A 5-year average of $4.3 million and a median of $3.7 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets surged 111.46% in 2023, then tumbled 52.65% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $2.5 million in 2022, then jumped by 106.77% to $5.1 million in 2023, then decreased by 11.66% to $4.5 million in 2024, then plunged by 33.8% to $3.0 million in 2025, then rose by 10.63% to $3.3 million in 2026.
- Business Quant data shows LXRX's Prepaid Assets at $3.3 million in Q1 2026, $3.0 million in Q4 2025, and $4.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lexicon Pharmaceuticals | 804.48 Mn | 633.82 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.32 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 4.09 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 3.32 Mn |
| Dec 31, 2024 | 4.53 Mn |
| Sep 30, 2024 | 6.71 Mn |
| Jun 30, 2024 | 7.68 Mn |
| Mar 31, 2024 | 7.01 Mn |
| Dec 31, 2023 | 5.13 Mn |
| Sep 30, 2023 | 4.29 Mn |
| Jun 30, 2023 | 6.12 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 2.48 Mn |
| Sep 30, 2022 | 2.82 Mn |
| Jun 30, 2022 | 2.90 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 2.16 Mn |
| Sep 30, 2021 | 3.06 Mn |
| Jun 30, 2021 | 4.60 Mn |